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AbstrAct
Spurious laboratory results are frequently encountered in patients with haematological disorders and lead to 
unnecessary additional laboratory investigations and inappropriate treatment. An 80-year-old woman, known 
with acute myeloid leukaemia, was admitted with suspected sepsis. Laboratory tests revealed a leukocyte count of 
358 x 109/L, serum potassium concentration of 2.6 mmol/L and partial pressure of arterial oxygen of 5.3 kPa. 
The patient did not display any clinical or electrocardiographic features of hypokalaemia and there were no signs 
of respiratory distress. A diagnosis of pseudohypokalaemia and pseudohypoxaemia was made and inappropriate 
therapeutic interventions were avoided. Pseudohypokalaemia and pseudohypoxaemia should always be a 
consideration in patients with hyperleukocytosis due to haematological malignancies, especially when there are no 
clinical features to support these findings. The inappropriate administration of potassium in such cases may cause 
serious cardiac arrythmias.
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INtrODUctION
Spurious laboratory results are frequently encountered 
in patients with haematological disorders and may lead 
to unnecessary additional laboratory investigations and 
inappropriate treatment [1]. Causes of spurious labora-
tory results may originate from pre-analytical (in vivo and 
in vitro), analytical or post-analytical factors [1]. In vivo 
factors include pre-existing comorbid diseases and drugs, 
whereas in vitro factors include phlebotomy technique, 
ambient temperature and turn-around time to sample 
analysis [1,2].
We present a case of an 80-year-old woman, known 
with acute myeloid leukaemia, who was found to have 
pseudohypokalaemia and pseudohypoxaemia, the iden-
tification of which resulted in the avoidance of inappro-
priate therapeutic interventions.  
cAsE PrEsENtAtION
An 80-year-old woman was admitted with the clinical 
picture of neutropaenic sepsis. She had been diagnosed 
with acute myeloid leukaemia not otherwise specified 
(AML-NOS) 4 months earlier and had not received 
any chemotherapy. She had hypertension, which was 
controlled with enalapril 5 mg twice daily and atenolol 
50 mg daily. There was no history of vomiting or 
diarrhoea and she was not using any diuretics. On 
admission her blood pressure was 136/85 mmHg, pulse 
rate was 99 beats per minute, temperature was 36.5°C 
and oxygen saturation while breathing ambient air was 
99% (pulse oximeter reading). Chest examination was 
unremarkable with no respiratory distress, abdominal 
examination revealed no hepatosplenomegaly and she 
had no muscle weakness. 
A chest radiograph revealed upper lobe interstitial 
infiltrates suggestive of pulmonary tuberculosis. Routine 
blood tests revealed a serum potassium concentration of 
2.6 mmol/L, leukocyte count of 358 x 109/L, haemoglobin 
concentration of 6.7 g/dL, platelet count of 62 x 109/L 
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and an arterial blood sample revealed severe hypoxaemia 
(Table 1). Hypokalaemia had also been noted with previous 
admissions. An electrocardiogram showed a multifocal 
atrial rhythm without U-waves or QT prolongation. Blood 
cultures were negative. 
A diagnosis of pseudohypoxaemia was made because of 
the absence of respiratory distress and normal oxygen 
saturation on pulse oximetry despite the severe hypox-
aemia in arterial blood. Owing to the absence of muscle 
weakness or electrocardiographic features of hypokalaemia, 
pseudohypokalaemia was also considered. A repeat serum 
sample was taken and hand-delivered to the laboratory 
on ice. The potassium concentration of this sample was 
4.2 mmol/L, confirming our suspicion of pseudohy-
pokalaemia. As a result, potassium supplementation as well 
as the administration of supplemental oxygen was avoided. 
Due to the overall poor prognosis, a decision was made to 
initiate palliative care. The patient died 3 days following 
admission.
DIscUssION
Pseudohypokalaemia is a phenomenon of spuriously 
reduced serum potassium concentration in vitro and needs 
to be recognised by clinicians to avoid the inappropriate 
administration of potassium, which may result in hyper-
kalaemia and life-threatening cardiac arrhythmias.   
Pseudohypokalaemia develops in cases of hyperleuko-
cytosis when leukocyte counts are greater than 100 x 
109/L, which occurs nearly exclusively in patients with 
haematological malignancies, particularly acute myeloid 
leukaemias (AML) [3]. A major mechanism for this phe-
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table 1.  Laboratory test results in a patient with acute myeloid leukaemia.
Laboratory test Ref. range Initial analysis Sample on ice
Serum
Sodium 136–145 mmol/L 139 139
Potassium 3.5–5.1 mmol/L 2.6 4.2
Urea 2.1–7.1 mmol/L 4.1 –
Creatinine 49–90 µmol/L 72 –
Leukocyte count 3.9–12.6 x 109/L 358.8 –
Haemoglobin 12.0–15.0 g/dL 6.7 –
Mean cell volume 78.9–98.5 fL 109.2 –
Platelet count 186–454 x 109/L 62 –
C-reactive protein <10 mg/L 345 –
Arterial blood sample*
pH 7.35–7.45 7.52 –
PaO2 11–13 kPa 5.3 –
PaCO2 4–6 kPa 3.9 –
Bicarbonate 24–26 mmol/L 24.6 –
Oxygen saturation 81%** –
Urine
Potassium mmol/L 39.2 –
Creatinine mmol/L 18.5 –
*Patient breathing ambient air. **Oxygen saturation by pulse oximeter reading = 99%.
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nomenon is the high sodium permeability of leukaemic cells 
with resultant increased activity of the sodium–potassium 
adenosine triphosphatase (Na+/K+-ATPase) pump, which 
causes the transcellular shift of potassium into leukaemic 
cells [4]. However, the monocytic subtype of AML may 
cause true hypokalaemia via renal potassium wasting [5]. 
Lysozymuria, that can affect renal tubular potassium 
reabsorption, is thought to be responsible [6]. In our 
patient, the absence of clinical and electrocardiographic 
features of hypokalaemia, as well as the hyperleukocytosis 
secondary to the non-monocytic subtype of AML, raised 
the suspicion of pseudohypokalaemia.   
Other causes of pseudohypokalaemia include blood 
samples taken from patients that were recently admin-
istered insulin and seasonal pseudohypokalaemia, which 
occurs at times of high room temperatures [7]. The effect 
of temperature was confirmed by Sodi et al., who compared 
the serum potassium concentrations of blood samples 
collected from primary care patients to samples collected 
in hospitalised patients and found relatively lower serum 
potassium concentrations during the summer months in 
patients in primary care [2]. Because samples from the 
primary care setting were transported to a central 
laboratory, the additional time spent during transit at 
higher ambient temperatures during the summer months 
was identified as the cause for this phenomenon. Increased 
activity of the Na+/K+-ATPase pump was identified as the 
mechanism for the intracellular potassium shift in vitro. 
Neither of these mechanisms was applicable in our patient. 
When pseudohypokalaemia is a consideration, cellular 
components should be separated from the serum or 
plasma promptly or the blood sample should be stored at 
4°C after collection to avoid the shifting of potassium [7]. 
Pseudohypoxaemia is less well recognised. It is a spurious 
reduction in partial pressure of oxygen in vitro. Red blood 
cells do not consume oxygen because of the absence of 
mitochondria and glucose metabolism occurs via anaerobic 
glycolysis. During physiological conditions, leukocyte and 
platelet concentrations are relatively low and therefore do 
not affect the partial pressure of oxygen in vitro [8]. 
However, haematological malignancies with hyperleuko-
cytosis or conditions with extreme thrombocytosis (platelet 
count >1000 x 109/L), may affect the partial pressure of 
oxygen because these cells maintain their high metabolism 
following phlebotomy and consume oxygen dissolved in 
the plasma [9]. A direct relationship exists between the 
severity of the hyperleukocytosis and the reduction in the 
oxygen  partial pressure [10]. As with pseudohypokalaemia, 
this phenomenon occurs frequently with AML of monocytic 
origin. The tendency for monocytes to produce hypoxaemia 
is due to their higher oxidative metabolism relative to other 
leukocytes [11].  
Before considering pseudohypoxaemia in a patient with 
leukaemia, other causes of hypoxaemia should first be 
excluded including pulmonary leukostasis, pneumonia and 
pulmonary embolism [12]. Our patient did not display any 
clinical features of sepsis or respiratory distress, making 
these causes unlikely. Also, our patient’s oxygen saturation, 
using the pulse oximeter, was 99% while breathing ambient 
air. The pulse oximeter is not affected by this in vitro 
phenomenon [13]. However, before fully relying on the 
pulse oximeter measurements, hypothermia and alkalosis 
should also be excluded as these two conditions shift the 
oxygen–haemoglobin dissociation curve to the left, which 
increases the oxygen saturation [12]. Neither of these 
conditions was present in our patient.    
Another potential mechanism for pseudohypoxaemia 
involves large numbers of leukaemic cells coating the 
electrode responsible for measuring the partial pressure of 
oxygen [14]. This may be avoided by simply measuring 
oxygen partial pressure using plasma rather than whole 
blood samples [14]. Other strategies for accurate 
measurement of oxygen partial pressure include continuous 
intra-arterial blood gas monitoring and adding sodium 
fluoride to the blood sample before blood gas analysis 
[15,16]. The latter reduces oxygen consumption by 
leukocytes. 
cONcLUsIONs
Pseudohypokalaemia and pseudohypoxaemia should 
always be a consideration in patients with hyperleuko-
cytosis due to haematological malignancies, especially when 
there are no clinical features to support these findings. 
Recognition of these conditions is important to avoid 
inappropriate therapy such as potassium supplementation, 
which may cause deadly cardiac arrhythmias. Pseudo-
hypokalaemia can be excluded by sending the blood sample 
to the laboratory on ice and non-invasive pulse oximeter 
measurements will exclude pseudohypoxaemia.
Ethical considerations
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